| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-07 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.12 | 6e-05 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0001 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0005 |